Modifying Adiposity Through Behavioral Strategies to Improve COVID-19 Rehabilitation
VA Office of Research and Development · with Baltimore VA Medical Center, South Texas Veterans Health Care System · NCT05880108
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Up to age 80 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 150
- US sites recruiting
- 2
- Study start
- June 3, 2024
- Record last updated
- June 1, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The research in this VA Merit will examine the effects of obesity and Post-COVID Conditions (PCC) on physical functioning, health-related quality of life, and adipose tissue inflammatory and cellular senescence profiles in older Veterans. Further, it will evaluate whether a weight loss intervention, including dietary modification and exercise, in obese Veterans with and without PCC will reduce systemic and adipose tissue inflammation and senescence and promote PCC recovery.
Being studied: 12-weeks of Weight Loss; 12-weeks of Weight Stability
Conditions: Post-COVID Conditions; Obesity
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- U.S. Veteran
- Self-reported COVID-19 naïve or COVID-19 > 90 days ago for lean and obese PCC naïve or documented COVID-19 for the lean and obese PCC groups (At least one PCC symptom >4 weeks)
- Body Mass Index: 19-25 or 30-50 kg/m2
Exclusion Criteria
- Neurologic, musculoskeletal, or other condition that limits subject's ability to complete study physical assessments
- Active inflammatory, COVID-19, autoimmune, infectious, hepatic (LFTs > 2.5 x WNL), renal (eGFR\<45), gastrointestinal, malignant, and psychiatric disease
- Uncontrolled diabetes (HbA1c >10% or the current use of insulin)
- Weight change within the past month of >5 kg
- Self-reported alcohol or drug abuse
- Anti-coagulant medication usage
Recruiting US locations
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
Baltimore, MD 21201
Site contact: Kristina Marcus, MS · 410-605-7000 · kristina.marcus@va.gov
South Texas Health Care System, San Antonio, TX
San Antonio, TX 78229-4404
Site contact: Tiffany Cortes, MD · 814-332-9939 · tiffany.cortes@va.gov
Study contacts (from the official record)
- Kristina Marcus, MS · (410) 605-7000 · kristina.marcus@va.gov
Similar studies in Maryland
All weight loss studies in Maryland →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
AstraZeneca
- Location
- Brooklyn, MD + 1 other US site
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1
A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD1043 in Healthy Adult Participants Living With Overweight and/or Obesity.
AstraZeneca
- Location
- Brooklyn, MD + 1 other US site
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASC35 Injection in Participants With Obesity or Overweight
Ascletis Pharma (China) Co., Limited
- Location
- Baltimore, MD
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase 1/2a Study of WVE-007 in Adults Living With Overweight or Obesity
Wave Life Sciences USA, Inc.
- Location
- Baltimore, MD
- Eligibility basics
- Ages 18–60